Pneumonies acquises a domicile: considerations sur la prise en charge ambulatoire. [Community-acquired pneumonia: considerations on ambulatory management]

Détails

ID Serval
serval:BIB_1F9E2BCDE370
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Pneumonies acquises a domicile: considerations sur la prise en charge ambulatoire. [Community-acquired pneumonia: considerations on ambulatory management]
Périodique
Schweizerische Medizinische Wochenschrift
Auteur(s)
Zanetti  G.
ISSN
0036-7672
Statut éditorial
Publié
Date de publication
03/1997
Peer-reviewed
Oui
Volume
127
Numéro
13
Pages
528-34
Notes
English Abstract
Journal Article --- Old month value: Mar 29
Résumé
Community-acquired pneumonia is a frequent disease in outpatients; its incidence is highest among persons at the extremes of age. Hospitalization is rarely required. Since most clinical studies are performed with hospitalized patients, available data are not always representative of the general population. For instance, the importance of some organisms, such as Mycoplasma pneumoniae, is underestimated, and the severity of the prognosis is overestimated in the literature. Identification of the causative organism is usually not cost-effective in outpatients. Therefore, therapy is most often empirical. In Switzerland, the majority of patients can be successfully treated with macrolides. Antibiotics may also be chosen according to the most probable organisms in a given patient, based on his age and underlying diseases; this last strategy may be more logical from the point of view of public health.
Mots-clé
Aged Aged, 80 and over Ambulatory Care Anti-Bacterial Agents/therapeutic use Community-Acquired Infections/diagnosis/microbiology Female Humans Macrolides Male Microbiological Techniques Pneumonia, Bacterial/*diagnosis/drug therapy/microbiology Pneumonia, Viral/diagnosis Prognosis
Pubmed
Web of science
Création de la notice
21/01/2008 10:04
Dernière modification de la notice
20/08/2019 12:55
Données d'usage